Clik here to view.
Connecting the genetic dots
Breast cancer is the most common cancer in women. Neurofibromatosis type 1 is a rare genetic disorder. A single gene may hold answers that could lead to new treatments for both. An aggressive breast...
View ArticleClik here to view.
High-throughput platform enables scientists to map activity of an emerging...
GRAND RAPIDS, Mich. (Nov. 28, 2018) — A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for cancer treatment. Dr. Scott Rothbart Published today...
View ArticleClik here to view.
New combination blood test for pancreatic cancer may catch disease earlier
Dr. Brian Haab GRAND RAPIDS, Mich. (Jan. 17, 2019) — A new approach to pancreatic cancer screening may help doctors detect the disease in people at high risk before it reaches more advanced and...
View ArticleDiagnosing a deadly cancer sooner and more definitively: An interview with...
Pancreatic cancer is an insidious disease that often evades detection until it has spread beyond the pancreas, seriously complicating treatment and reducing the chances of successful remission. For...
View Article10 things to know about pancreatic cancer
On March 12, the Institute will host A Focus on Pancreatic Cancer: From Foundations to Early Detection, a part of our Public Lecture Series, which is designed to engage and inform the community. The...
View ArticleWhat is basic research and why is it important?
On March 12, the Institute will host A Focus on Pancreatic Cancer: From Foundations to Early Detection, a part of our Public Lecture Series, which is designed to engage and inform the community. The...
View ArticleWATCH: Van Andel Institute Public Lecture Series: A Focus on Pancreatic Cancer
The first public lecture of 2019 at Van Andel Institute, A Focus on Pancreatic Cancer, from Foundations to Early Detection was held on March 12. Attendees learned why basic research is fundamental in...
View ArticleClik here to view.
Blocking epigenetic “Swiss army knife” may be a new strategy for treating...
GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a protein called UHRF1 switches on hundreds of cancer-fighting genes, impairing...
View ArticleCombating cancer from the lab to the clinic
May is Cancer Research Month, which raises awareness for the efforts underway to prevent, treat and, ultimately, cure cancer. When it comes to combating cancer, collaboration is one of the most...
View ArticleFighting cancer is an ever-evolving challenge
This year’s Origins of Cancer symposium explores cancer evolution, from genetics to selection pressure By Guillermo Flores and Leslie Wyman Van Andel Institute Graduate School Ph.D. students and...
View Article10 research trends we’re excited to watch in the next decade
With a new decade comes a new world of possibility and innovation waiting to be unleashed in labs at Van Andel Institute and across the globe. As we take our first steps into the 2020s, here are 10...
View ArticleClik here to view.
World Cancer Day 2020: What energizes VAI scientists about the future of...
February is National Cancer Prevention Month, and Feb. 4, 2020, is World Cancer Day. To mark the occasion, Van Andel Institute scientists shared what most excites them about the directions cancer...
View ArticleExplainer: What are mitochondria?
If you ask high school biology students about mitochondria, they’re likely to respond with the same answer: mitochondria are the powerhouses of the cell. But let’s get more specific. To start,...
View ArticleClik here to view.
Van Andel Institute scientists win Team Science Awards from American...
Peter Laird, Ph.D. GRAND RAPIDS, Mich. (June 22, 2020) — The American Association for Cancer Research has awarded Van Andel Institute Professor Peter W. Laird, Ph.D., Director’s Scholar Stephen B....
View ArticleClik here to view.
Explainer: How do gene mutations happen?
Many diseases and disorders studied at Van Andel Institute have genetic links, including cancer and Parkinson’s disease. Gene mutations, or changes to genes, play a major role in disease. Here’s a...
View ArticleVan Andel Institute to serve as Cancer MoonshotSM Biorepository
GRAND RAPIDS, Mich. (September 15, 2020) — Van Andel Institute’s Biorepository has been awarded a $2.7 million, two-year subcontract from the Frederick National Laboratory for Cancer Research currently...
View ArticleClik here to view.
Graduate student spotlight: Investigating a cancer linked to a rare genetic...
Throughout the year, we highlight Van Andel Institute Graduate School’s doctoral students. This month features Lauren McGee, a student in the lab of Dr. Matt Steensma. Lauren studies a tough-to-treat...
View ArticleClik here to view.
New experimental blood test determines which pancreatic cancers will respond...
GRAND RAPIDS, Mich. (Oct. 22, 2020) — Scientists have developed a simple, experimental blood test that distinguishes pancreatic cancers that respond to treatment from those that do not. This critical...
View ArticleA look back at 2020
The past year has challenged us in new and unexpected ways. Yet through it all, we have been inspired by the strength and resilience of our community. We are deeply grateful to be part of West...
View ArticleWhat you need to know about colorectal cancers
In 2020, colorectal cancers accounted for 8%, or 147,950, of new cancer cases, making them the fourth most common type of new cancers diagnosed in the U.S. (excluding skin cancers). 1Colon and rectal...
View Article